ALT-802

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALT-802

Drug Alias NameSTAR fusion agents (Altor Bioscience)c264sc-TCR-Ig (Altor)STAR-Ig (Altor)single-chain T-cell receptor IgG1 fusion protein (HLA-A2 restricted) (Altor)ALT-802

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionTumor protein p53 modulators

TargetsTumor protein p53

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAltor Bioscience Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAltor Bioscience Corp

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A